Trials / Conditions / Aggressive Variant Prostate Carcinoma
Aggressive Variant Prostate Carcinoma
3 registered clinical trials studyying Aggressive Variant Prostate Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Zanzalintinib in Men With Aggressive Variant Prostate Cancer NCT07218666 | Deepak Kilari | Phase 2 |
| Active Not Recruiting | Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of NCT04592237 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers NCT04388852 | M.D. Anderson Cancer Center | Phase 1 |